FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Man Indicted for Selling Counterfeit Cancer Drugs

[ Price : $8.95]

The Justice Department says a resident of India has been indicted on federal charges of trafficking in fake cancer drugs sold in t...

New Quantitative Medicine CoE Resources

[ Price : $8.95]

The CDER Quantitative Medicine Center of Excellence posts four new resources.

Biosimilar User Fee Rates For FY 2025

[ Price : $8.95]

Federal Register notice: FDA set biosimilar user fee rates for fiscal year 2025.

OTC Monograph FY 2025 User Fee Rates

[ Price : $8.95]

Federal Register notice: FDA posts the over-the-counter monograph order request fee rates for fiscal year 2025.

Info Collection on FDA Quantitative Testing

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Generic Clearance for Quantitative Tes...

CDER Used AI/ML in Kineret EUA

[ Price : $8.95]

CDER explains how it used artificial intelligence/machine learning (AI/ML) to help identify the patient population most likely to ...

Zymedi Gets Orphan Status for ZMA001

[ Price : $8.95]

FDA grants Zymedi an orphan drug designation for ZMA001, a monoclonal antibody in development for pulmonary arterial hypertension.

Alert on Megadyne Patient Return Electrodes

[ Price : $8.95]

FDA and Health Canada issue a notice alerting healthcare providers and facilities about the safe use of Megadyne Medical Products ...

Ways to Improve OS Data Collection, Analysis

[ Price : $8.95]

Researchers from FDA and other entities recommend ways to improve the collection and analysis of overall survival (OS) data in can...

Stakeholder Comments on Cell, Gene Guidance

[ Price : $8.95]

Three stakeholders recommend changes to an FDA draft guidance on human- and animal-derived materials in cell and gene therapeutic ...